文献速递细菌感染、耐药与抗菌药物

临床微生物学中抗生素异质性耐药检测:当前与新兴方法

Detection of antibiotic heteroresistance in clinical microbiology: current and emerging methodologies.
PubMed 文献 · Clin Microbiol Infect · 2026-09-12

该综述系统评价了抗生素异质性耐药(HR)的现有及新兴检测方法,指出表型群体分析谱是定义HR的参考方法但难以常规开展,分子与计算工具可提升低比例耐药亚群检出,目前仍需方法学标准化和临床验证以推动HR检测进入常规诊断。

要点

  • 常规药敏试验主要评估优势菌群,可能漏检异质性耐药。
  • 群体分析谱是HR定义参考方法,但操作繁琐、周转慢、标准化不足。
  • 分子与机器学习方法有前景,但需更广泛验证和统一判读标准。

核心结论

  • 现有证据支持HR具有临床相关性,但其与不良结局的关联因菌种和抗生素类别而异。
  • 需要统一的方法学和经临床验证的判读标准,以支持将HR评估整合进常规诊断。
  • 前瞻性多中心研究和进一步标准化(包括与EUCAST和CLSI合作)对推进临床实施很重要。

研究设计与样本

  • 叙述性综述,基于PubMed检索,并补充筛选关键参考文献列表及EUCAST和CLSI相关文件。
  • 优先纳入同行评议文献。

主要发现

  • 表型方法尤其是群体分析谱仍是HR定义的参考方法,但工作量大、周转时间长且标准化有限,限制常规开展。
  • 改良药敏试验、代谢试验和单细胞平台等替代策略在速度或通量上有提升,但需更广泛验证。
  • 定量PCR、微滴数字PCR、靶向深度测序和全基因组测序等分子方法可改善对少数耐药决定因子的检测。
  • 整合表型和基因组数据的机器学习模型等新兴计算框架,是规模化预测HR的有前景方向。

临床怎么用

  • 临床微生物实验室应认识常规药敏试验可能漏检HR,对疑似病例可考虑补充表型或分子检测。
  • 临床解读药敏结果时需结合HR可能性,尤其在使用常规方法报告敏感但临床疗效不佳时。
  • 推动HR检测进入常规诊断需依托方法学标准化和经临床验证的判读标准。

局限性

  • 为叙述性综述,非系统评价,检索策略和纳入标准未按系统评价流程报告。
  • HR与不良结局的关联因菌种和抗生素类别而异,证据一致性有限。
  • 现有HR检测方法普遍缺乏标准化和临床验证的判读标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antibiotic heteroresistance (HR) is characterised by the coexistence of susceptible and resistant subpopulations within an apparently isogenic bacterial isolate. Because routine antimicrobial susceptibility testing (AST) primarily assesses the dominant population, HR may escape detection, potentially leading to discrepancies between laboratory susceptibility categorisation and the underlying bacterial population structure. OBJECTIVES: The study aimed to provide a critical and practice-oriented evaluation of current and emerging methodologies for HR detection and to discuss their strengths, limitations, and potential for clinical implementation. SOURCES: Narrative review based on PubMed searches, complemented by screening of key reference lists and relevant European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical and Laboratory Standards Institute (CLSI) documents. Peer-reviewed literature was prioritised. CONTENT: Phenotypic approaches, particularly population analysis profiling, remain the reference method for HR definition, but their labour-intensive workflows, long turnaround times, and limited standardisation restrict routine implementation. Alternative strategies, including modified AST assays, metabolic assays, and single-cell platforms, offer gains in speed or throughput but require broader validation. Molecular approaches such as quantitative PCR, droplet digital PCR, targeted deep sequencing, and whole-genome sequencing improve detection of minority resistance determinants. Emerging computational frameworks, including machine learning models integrating phenotypic and genomic data, represent a promising frontier for scalable HR prediction. IMPLICATIONS: Available evidence supports the clinical relevance of HR, although its association with adverse outcomes varies across bacterial species and antibiotic classes. Harmonised methodologies and clinically validated interpretive criteria are needed to support integration of HR assessment into routine diagnostics. Prospective multicentre studies and further standardisation, including engagement with EUCAST and CLSI, will be important to advance clinical implementation.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Squitieri D, Menchinelli G, Rohde H, et al. Detection of antibiotic heteroresistance in clinical microbiology: current and emerging methodologies. Clin Microbiol Infect. 2026. PMID: 42731626. doi:10.1016/j.cmi.2026.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。